Home
Department of Clinical Medicine

News archive for Department of Clinical Medicine

CCBIO initiated its research school – CCBIO Research School for Cancer Studies (RSCS) – very early on, and the RSCS has since the startup in 2014 undergone a steady progress and expansion of the course portfolio. Now that CCBIO’s parent department the Department of Clinical Medicine has been assigned an FKB center (Centre for Clinical Treatment Research) – Neuro-SysMed – CCBIO is happy to be able... Read more
CCBIO’s PhD course CCBIO905 Methods in Cancer Biomarker Research was for the first time run on a digital platform October 27-29, 2020. The course was well attended, 80 participants followed selected lectures for non-ECTS participation, and 34 students completed the course with ECTS credits. The participants signed in from 15 different universities and 8 different countries with the majority of... Read more
Marte-Helene Bjørk – Department of Clinical Medicine
Nils Erik Gilhus – Department of Clinical Medicine
In collaboration with the Vascular Biology Program (VBP), Boston Children’s Hospital, CCBIO recently completed the second CCBIO INTPART long course CCBIO907. This year, the course was given in digital format, and it was well visited by local students and researchers, participants from other institutions all over Norway, and also from Finland, Sweden and Denmark, in addition to some from other... Read more
February 13-14 2020, the second Mohn Nutrition Research Lab seminar was held.
The Leader of the Centre for Nutrition, Gülen Arslan Lied, is awarded The Crown Prince Haakon Research Award for Asthma and Allergy 2020.
CCBIO Postdoc Katrin Kleinmanns, together with CCBIO PhD Katharina Bischoff and Researcher Vibeke Fosse, recently published 2 articles in EBioMedicine. Their work describing CD24-targeted near-infrared (NIR) fluorescence imaging in patient-derived xenograft (PDX) models of high-grade serous ovarian carcinoma (HGSOC), confirms an improvement of cytoreduction of ovarian cancer in PDX orthotopic... Read more
Even only few hours with cognitive behavioural therapy has very good effect on persons with hypochondria 10 years after treatment.
The pandemic situation and lockdown of campus has forced CCBIO to think new in order to fulfill the goals for the CCBIO Research School for Cancer Studies. On fairly short notice, the 2 planned spring courses were rescheduled to new dates and organized through digital platforms. Despite of limited time to get the word out, registration for both courses soon had to be closed, due to great interest... Read more
Mitochondrial failure contributes to Creutzfeldt-Jacob disease, study suggests.
A new study at the Department of Clinical Medicine and Haukeland University Hospital unfolds important new knowledge about altered gene regulation in Parkinson’s disease.
The CCBIO International Faculty was established to support the Centre through active collaborations and strategic advice. In addition to the 13 already affiliated members, we have now recruited a new member, Marta Bertolaso from Rome, Italy, and have the pleasure of presenting her and her unique contribution to CCBIO.
CCBIO applied for and recently received continued support from the Research Council of Norway (RCN) and the Norwegian Agency for International Cooperation and Quality Enhancement in Higher Education (DIKU) for phase 2 of the INTPART project: “Bergen-Harvard Cancer Studies phase 2: Continued Partnership for Responsible Education, Research and Innovation Excellence.”
CCBIO operates within the health services in addition to the Faculty of Medicine at the UiB and is subject to the guidelines issued by both institutions (see below links). As a consequence, we are reducing our activities accordingly. Please check the calendar for details. Notably, the CCBIO Annual Symposium and the Satellite Symposium have been cancelled.
February 13-14, the second Mohn Nutrition Research Lab seminar was held.
The coronavirus outbreak (COVID-19) is confirmed as pandemic by WHO, 11. march. To what extent should we fear the coronavirus? We have asked virus expert Professor Rebecca Cox.

Pages